Cargando…

Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches

Pancreatic ductal adenocarcinoma (PDAC) remains a devastating human malignancy with poor prognosis and low survival rates. Several cellular mechanisms have been linked with pancreatic carcinogenesis and also implicated in inducing tumor resistance to known therapeutic regimens. Of various factors, i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thyagarajan, Anita, Alshehri, Mamdouh Salman A., Miller, Kelly L.R., Sherwin, Catherine M., Travers, Jeffrey B., Sahu, Ravi P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893814/ https://www.ncbi.nlm.nih.gov/pubmed/31652904 http://dx.doi.org/10.3390/cancers11111627

Ejemplares similares

Dietary Polyphenols in Cancer Chemoprevention: Implications in Pancreatic Cancer
por: Thyagarajan, Anita, et al.
Publicado: (2020)

Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
por: Sirhan, Zaid, et al.
Publicado: (2023)

Implications of Aspirin for Melanoma Treatment: A Short Perspective
por: Thyagarajan, Anita, et al.
Publicado: (2017)

Exploiting the relevance of CA 19-9 in pancreatic cancer
por: Salleh, Syaza, et al.
Publicado: (2020)

Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells
por: Chauhan, Shreepa J., et al.
Publicado: (2020)

Evaluation of SARS-CoV-2 Spike S1 Protein Response on PI3K-Mediated IL-8 Release
por: Borchers, Christina, et al.
Publicado: (2021)

The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer
por: Sirhan, Zaid, et al.
Publicado: (2022)

Topical application of gemcitabine generates microvesicle particles in human and murine skin
por: Thyagarajan, Anita, et al.
Publicado: (2022)

Exposure to diesel exhaust particulates and desert sand dust generates microvesicle particles and platelet‐activating factor agonists
por: Thyagarajan, Anita, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
por: Katoh, Hiroshi, et al.
Publicado: (2015)

The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
por: Dong, Peng, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
por: Law, Andrew M. K., et al.
Publicado: (2020)

Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization
por: Thyagarajan, Anita, et al.
Publicado: (2017)

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
por: Li, Kai, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells in Patients With Acute Pancreatitis With Increased Inhibitory Function
por: Ding, Lili, et al.
Publicado: (2022)

Creatine and Nicotinamide Prevent Oxidant-Induced Senescence in Human Fibroblasts
por: Mahajan, Avinash S., et al.
Publicado: (2021)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells
por: Thyagarajan, Anita, et al.
Publicado: (2018)

Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
por: Metzger, Philipp, et al.
Publicado: (2019)

The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity
por: Zhang, Qi, et al.
Publicado: (2015)

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
por: Wesolowski, Robert, et al.
Publicado: (2013)

Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
por: Ma, Jie, et al.
Publicado: (2018)

Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
por: Won, Woong-Jai, et al.
Publicado: (2019)

Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes
por: Wang, Yijun, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
por: Fan, Rong, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway
por: Thyagarajan, Anita, et al.
Publicado: (2017)

Melatonin as a Repurposed Drug for Melanoma Treatment
por: Pathipaka, Rachana, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
por: Shi, Houhui, et al.
Publicado: (2021)

Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
por: Siret, Carole, et al.
Publicado: (2020)

Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
por: Metzger, Philipp, et al.
Publicado: (2019)

Ubiquitinated Proteins in Exosomes Secreted by Myeloid-Derived Suppressor Cells
por: Burke, Meghan C., et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
por: Rowlands, Marianna, et al.
Publicado: (2021)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3e5cngib9hqmlmbkp27tqdeff7